Novo Integrated Sciences (NVOS) Revenue & Revenue Breakdown
Novo Integrated Sciences Revenue Highlights
Latest Revenue (Y)
$12.57M
Latest Revenue (Q)
$3.15M
Main Segment (Y)
Corporate Segment
Novo Integrated Sciences Revenue by Period
Novo Integrated Sciences Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-08-31 | $12.57M | 7.11% |
| 2022-08-31 | $11.74M | 26.14% |
| 2021-08-31 | $9.31M | 18.38% |
| 2020-08-31 | $7.86M | -16.57% |
| 2019-08-31 | $9.42M | 5.93% |
| 2018-08-31 | $8.89M | 11.70% |
| 2017-08-31 | $7.96M | 10.93% |
| 2016-08-31 | $7.18M | 100.00% |
| 2014-12-31 | - | 100.00% |
| 2013-12-31 | - | 100.00% |
| 2012-12-31 | - | 100.00% |
| 2011-12-31 | - | 100.00% |
| 2010-12-31 | - | 100.00% |
| 2009-12-31 | - | 100.00% |
| 2008-12-31 | - | 100.00% |
| 2007-12-31 | - | 100.00% |
| 2006-12-31 | - | 100.00% |
| 2005-12-31 | - | 100.00% |
| 2004-12-31 | - | - |
Novo Integrated Sciences generated $12.57M in revenue during NA 2023, up 7.11% compared to the previous quarter, and up 141.35% compared to the same period a year ago.
Novo Integrated Sciences Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-05-31 | $3.15M | -0.59% |
| 2024-02-29 | $3.17M | -18.52% |
| 2023-11-30 | $3.89M | 17.80% |
| 2023-08-31 | $3.30M | 0.31% |
| 2023-05-31 | $3.29M | 28.81% |
| 2023-02-28 | $2.56M | -25.23% |
| 2022-11-30 | $3.42M | -141.98% |
| 2022-08-31 | $-8.15M | -158.80% |
| 2022-05-31 | $13.85M | 382.77% |
| 2022-02-28 | $2.87M | -9.26% |
| 2021-11-30 | $3.16M | 17.42% |
| 2021-08-31 | $2.69M | 13.10% |
| 2021-05-31 | $2.38M | 14.70% |
| 2021-02-28 | $2.08M | -3.69% |
| 2020-11-30 | $2.16M | 16.84% |
| 2020-08-31 | $1.84M | 77.69% |
| 2020-05-31 | $1.04M | -57.25% |
| 2020-02-29 | $2.43M | -4.70% |
| 2019-11-30 | $2.55M | 5.30% |
| 2019-08-31 | $2.42M | -2.79% |
| 2019-05-31 | $2.49M | 13.14% |
| 2019-02-28 | $2.20M | -4.81% |
| 2018-11-30 | $2.31M | 6.45% |
| 2018-08-31 | $2.17M | -6.52% |
| 2018-05-31 | $2.32M | 8.26% |
| 2018-02-28 | $2.15M | -4.78% |
| 2017-11-30 | $2.25M | 1.51% |
| 2017-08-31 | $2.22M | 6.24% |
| 2017-05-31 | $2.09M | 100.00% |
| 2017-02-28 | - | -100.00% |
| 2016-12-31 | $1.82M | -0.94% |
| 2016-09-30 | $1.84M | 100.00% |
| 2016-06-30 | - | 100.00% |
| 2016-03-31 | - | 100.00% |
| 2015-12-31 | - | 100.00% |
| 2015-09-30 | - | 100.00% |
| 2015-06-30 | - | 100.00% |
| 2015-03-31 | - | 100.00% |
| 2014-12-31 | - | 100.00% |
| 2014-09-30 | - | 100.00% |
| 2014-06-30 | - | 100.00% |
| 2014-03-31 | - | 100.00% |
| 2013-12-31 | - | 100.00% |
| 2013-09-30 | - | 100.00% |
| 2013-06-30 | - | 100.00% |
| 2013-03-31 | - | 100.00% |
| 2012-12-31 | - | 100.00% |
| 2012-09-30 | - | 100.00% |
| 2012-06-30 | - | 100.00% |
| 2012-03-31 | - | 100.00% |
| 2011-12-31 | - | 100.00% |
| 2011-09-30 | - | 100.00% |
| 2011-06-30 | - | 100.00% |
| 2011-03-31 | - | 100.00% |
| 2010-12-31 | - | 100.00% |
| 2010-09-30 | - | 100.00% |
| 2010-06-30 | - | 100.00% |
| 2010-03-31 | - | 100.00% |
| 2009-12-31 | - | 100.00% |
| 2009-09-30 | - | 100.00% |
| 2009-06-30 | - | 100.00% |
| 2009-03-31 | - | 100.00% |
| 2008-12-31 | - | 100.00% |
| 2008-09-30 | - | 100.00% |
| 2008-06-30 | - | 100.00% |
| 2008-03-31 | - | 100.00% |
| 2007-12-31 | - | 100.00% |
| 2007-09-30 | - | 100.00% |
| 2007-06-30 | - | - |
Novo Integrated Sciences generated $3.15M in revenue during Q3 2024, up -0.59% compared to the previous quarter, and up 123.29% compared to the same period a year ago.
Novo Integrated Sciences Revenue Breakdown
Novo Integrated Sciences Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Aug 23 | Aug 22 | Aug 21 |
|---|---|---|---|
| Corporate Segment | $9.70K | $3.18K | - |
| Healthcare Services | - | $8.40M | $8.86M |
| Product Sales | - | $3.34M | - |
| Product Manufacturing and Development | - | - | $447.56K |
Novo Integrated Sciences's latest annual revenue breakdown by segment (product or service), as of Aug 23: Corporate Segment (100.00%).
Quarterly Revenue by Product
| Product/Service | May 24 | Nov 23 | Aug 23 | May 23 | Aug 22 | May 22 | Feb 22 | Nov 21 |
|---|---|---|---|---|---|---|---|---|
| Product Manufacturing And Development | $968.52K | - | - | - | - | - | - | - |
| Corporate Segment | - | $78.25K | - | - | - | - | - | - |
| Product Manufacturing and Development | - | - | - | $1.27M | $995.65K | $982.30K | - | - |
| Healthcare Services | - | - | - | $2.02M | $2.14M | - | - | - |
| Product Sales | - | - | - | - | $-10.29M | $11.65M | - | - |
| HealthCare Services | - | - | - | - | - | $2.20M | $1.87M | $2.18M |
Novo Integrated Sciences's latest quarterly revenue breakdown by segment (product or service), as of May 24: Product Manufacturing And Development (100.00%).
Novo Integrated Sciences Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| THC | Tenet Healthcare | $20.55B | $5.10B |
| UHS | Universal Health Services | $14.28B | $3.91B |
| CYH | Community Health Systems | $12.49B | $3.14B |
| DVA | DaVita | $12.14B | $3.19B |
| AGL | agilon health | $4.32B | $1.48B |
| AMN | AMN Healthcare Services | $3.79B | $740.68M |
| BKD | Brookdale Senior Living | $3.02B | $777.54M |
| ACHC | Acadia Healthcare Company | $2.93B | $796.04M |
| CANO | Cano Health | $2.74B | $788.07M |
| AVAH | Aveanna Healthcare | $1.90B | $490.65M |
| PIII | P3 Health Partners | $1.27B | $388.49M |
| LFST | LifeStance Health Group | $1.06B | $300.44M |
| PNTG | Pennant Group | $544.89M | $156.91M |
| TOI | Oncology Institute | $324.24M | $94.67M |
| NVOS | Novo Integrated Sciences | $12.57M | $3.15M |
| BACK | IMAC | $5.20M | - |
| IONM | Assure | $255.00K | $9.00K |
NVOS Revenue FAQ
What is Novo Integrated Sciences’s yearly revenue?
Novo Integrated Sciences's yearly revenue for 2023 was $12.57M, representing an increase of 7.11% compared to 2022. The company's yearly revenue for 2022 was $11.74M, representing an increase of 26.14% compared to 2021. NVOS's yearly revenue for 2021 was $9.31M, representing an increase of 18.38% compared to 2020.
What is Novo Integrated Sciences’s quarterly revenue?
Novo Integrated Sciences's quarterly revenue for Q3 2024 was $3.15M, a -0.59% decrease from the previous quarter (Q2 2024), and a -4.28% decrease year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $3.17M, a -18.52% decrease from the previous quarter (Q1 2024), and a 24.02% increase year-over-year (Q2 2023). NVOS's quarterly revenue for Q1 2024 was $3.89M, a 17.80% increase from the previous quarter (Q4 2023), and a 13.80% increase year-over-year (Q1 2023).
What is Novo Integrated Sciences’s revenue growth rate?
Novo Integrated Sciences's revenue growth rate for the last 3 years (2021-2023) was 35.11%, and for the last 5 years (2019-2023) was 33.44%.
What are Novo Integrated Sciences’s revenue streams?
Novo Integrated Sciences's revenue streams in g 23 are Corporate Segment
What is Novo Integrated Sciences’s main source of revenue?
For the fiscal year ending Aug 23, the largest source of revenue of Novo Integrated Sciences was Corporate Segment. This segment made a revenue of $9.7K, representing 100.00% of the company's total revenue.